Biggest News Aggregation in the World
📰 Phase News

Page 1480 - Phase News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Phase. Real-time updates on events, politics, business and more.

Graycliff Exploration Ltd.: Graycliff Exploration Commences Phase Two of Exploration at Shakespeare Gold Project

Graycliff Exploration Ltd.: Graycliff Exploration Commences Phase Two of Exploration at Shakespeare Gold Project Graycliff Exploration Limited (the " Company" or " Graycliff") (CSE: GRAY) (OTCQB: GRYCF) (FSE: GE0) is pleased to announce that drilling has resumed as part of phase two of the 2020/2021 exploration program at the Companys Shakespeare Gold Project (" Shakespeare") located on the prolific Canadian Shield near Sudbury, Ontario. The Company is awaiting assay results from the final thre...
Canadian Shield Canada General James Macintosh Bruce Durham Graycliff Exploration Ltd Company Shakespeare

Reportable, Inc.: Health Canada Clears Pacylex Pharmaceuticals for New Phase 1 Clinical Trial to Evaluate PCLX-001 Capsules in the Treatment of Hematologic and Solid Tumor Cancers

Reportable, Inc.: Health Canada Clears Pacylex Pharmaceuticals for New Phase 1 Clinical Trial to Evaluate PCLX-001 Capsules in the Treatment of Hematologic and Solid Tumor Cancers Key Takeaways: Scientists at the University of Alberta have recently published evidence that a new drug could work in blood cancers by targeting B-cell signaling. Scientists at the University of Alberta also published a study showing potential in breast cancer. PCLX-001 led to significant tumor regression in mouse mod...
Kostenloser Wertpapierhandel Roche Rituxan Luc Berthiaume University Of Alberta Alberta Newsfile Corp University Of Dundee

Frustration builds by some who can't get COVID-19 vaccination as the state moves to the next phase

Frustration builds for some who cant get COVID-19 vaccination as the state moves to the next phase Vaccine Queens help 1,100 people find appointments Two Ohio women, who have dubbed themselves the "Vaccine Queens," are on a mission to get as many Ohioans vaccinated as possible. By: Tracy Carloss and last updated 2021-03-10 12:57:04-05 CLEVELAND — Beginning Thursday, more than a million Ohioans will become eligible for the COVID-19 vaccination. The state moves into the 1-D a...
Cathy Cheshire Marla Zwinggi Beginning Thursday Vaccine Queens Covid 19 Northeast Ohio News
Source: wcpo.com

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

Transgene Expands Phase II Clinical Trial of Therapeutic Vaccine TG4001 in Combination With Avelumab Versus Avelumab Monotherapy in Patients With HPV16-positive Anogenital Cancers

Transgene Expands Phase II Clinical Trial of Therapeutic Vaccine TG4001 in Combination With Avelumab Versus Avelumab Monotherapy in Patients With HPV16-positive Anogenital Cancers - Trial will focus on patients without liver metastases, based on encouraging data in Phase Ib/II study - Trial targets indications where clinical outcomes can be improved versus standard therapeutic options and immune checkpoint inhibitors ("ICIs") - Continued clinical collaboration with Merck KGaA, Darmstadt, Ger...
Distrito Federal United States United Kingdom Lucie Larguier Christophe Le Tourneau Le Tourneau

Lilly' Bamlanivimab & Etesevimab Reduce Hospitalizations & Death In Phase 3 Trial For Early COVID-19

INDIANAPOLIS (dpa-AFX) - Eli Lilly and Co.'s (LLY) bamlanivimab (LY-CoV555) 700 mg and etesevimab (LY-CoV016) 1400 mg together significantly reduced COVID-19 related hospitalizations and deaths
Eli Lilly European Union Melinda Gates Foundation Co Vid எலி லில்லி ஐரோப்பிய தொழிற்சங்கம்

Press Release : FDA accepts the new drug application for review of Idorsia's daridorexant for the treatment of adult patients with insomnia

Message : Required fields -- The application includes robust data from the Phase 3 registration program, which demonstrated efficacy of daridorexant on objective and subjective sleep parameters, and an improvement in daytime functioning, while maintaining a favorable safety profile Allschwil, Switzerland -- March 10, 2021 Idorsia Ltd (SIX: IDIA) today announced that the US Food and Drug Administration (FDA) has accepted the new drug application (NDA) for review of Idorsias ...
Switzerland General Jean Paul Clozel Idorsia Ltd European Union Drug Administration Paul Clozel

Adocia Initiates Phase 2 Clinical Trial for M1Pram in Patients with Type 1 Diabetes

Adocia Initiates Phase 2 Clinical Trial for M1Pram in Patients with Type 1 Diabetes 1c The study has been designed to define parameters for the upcoming Phase 3 trial planned for 2022 This study follows the promising results of the proof-of-concept Phase 1 trial announced on September 15, 2020 Regulatory News: Adocia (Paris:ADOC) (Euronext Paris: FR0011184241 ADOC), a clinical stage biopharmaceutical company focused on diabetes treatment and other metabolic diseases, announced today the initiat...
James Salierno Olivier Soula Eli Lilly Pramlintide Biochaperone Raimund Gabriel Truth Group

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science